Clinical Research
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,024
NCT04656613
A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE
Phase: Phase 3
Role: Collaborator
Start: Dec 31, 2020
Completion: Dec 31, 2021
NCT06084988
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
Phase: Phase 1/2
Start: Nov 8, 2023
Completion: Apr 7, 2025
NCT06063590
A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients
Start: Nov 28, 2023
Completion: Apr 1, 2025
Loading map...